AI model aims to predict heart risks after hip surgery in seniors

NCT ID NCT07709377

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study develops and tests an artificial intelligence-based tool to predict major heart complications—such as heart attack, heart failure, or dangerous heart rhythms—in adults aged 60 and older after hip fracture surgery. Researchers will analyze data from 600 patients across two hospitals, using machine learning to identify key risk factors and build a prediction model. The goal is to help doctors better identify high-risk patients and improve their care, without any experimental treatments or changes to standard medical practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a practical tool that helps doctors identify elderly patients at highest risk of heart complications after hip fracture surgery, potentially reducing deaths and improving recovery.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test any new therapy. The prediction model may not work as well in other hospitals or patient groups, and machine learning models can sometimes be hard to interpret or apply in everyday care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ELDERLY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Anzhen Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100029, China

  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, 100029, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.